2016
DOI: 10.1111/bjd.15140
|View full text |Cite
|
Sign up to set email alerts
|

The reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index ( CDASI ) among dermatologists, rheumatologists and neurologists

Abstract: Background Previous studies have shown that skin disease in dermatomyositis (DM) is best assessed using the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI). Although the CDASI has been validated for use by dermatologists, it has not been validated for use by other physicians such as rheumatologists and neurologists, who also manage DM patients and assess skin activity in clinical trials. The purpose of this study is to assess the reliability of the CDASI among dermatologists, rheumatologists,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
11
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 24 publications
(12 citation statements)
references
References 14 publications
0
11
0
1
Order By: Relevance
“…This assessment The Cutaneous Disease Area Severity Index (CDASI) was developed in order to provide systematic documentation of skin involvement in dermatomyositis. has been proven as valid regarding treatment response, also for rheumatologists and neurologists [16,17]. A DM patient's quality of life is correlated with the results found in this index [18].…”
Section: Clinical Appearance Of Adult Dmmentioning
confidence: 91%
“…This assessment The Cutaneous Disease Area Severity Index (CDASI) was developed in order to provide systematic documentation of skin involvement in dermatomyositis. has been proven as valid regarding treatment response, also for rheumatologists and neurologists [16,17]. A DM patient's quality of life is correlated with the results found in this index [18].…”
Section: Clinical Appearance Of Adult Dmmentioning
confidence: 91%
“…Until now, the reliability and validity of the CDASI has been demonstrated for dermatologists alone. The results from this study extend the use of this instrument to nondermatologists and represent a meaningful step towards ensuring the inclusion of skin disease outcomes with respect to treatment response in all future DM‐centred investigations, whether led by dermatologists or not. This and other similar efforts provide a platform for the systematic evaluation of novel and repurposed therapies for rare autoimmune and inflammatory diseases that involve the skin.…”
mentioning
confidence: 67%
“…In this issue of the BJD , Tiao et al . assessed the reliability of the CDASI when used by dermatologists, rheumatologists and neurologists, the latter two groups representing specialists who also routinely care for patients with DM and participate in DM clinical trials.…”
mentioning
confidence: 99%
“…Cutaneous ulcerations commonly occur over Gottron papules or in areas with the Gottron sign, and often affect the skin over the extensor joint surfaces, although they could be found anywhere [6]. An evaluation of the lesions using objective measurements, such as the Cutaneous Dermatomyositis Disease Area and Severity Index, is useful for checking the severity of the lesions and assessing their response to treatment [7].…”
Section: Discussionmentioning
confidence: 99%